Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision label was updated from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:41:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-25T15:27:53.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The acute myeloid leukemia study is now listed as active but no longer recruiting participants. Its latest record history also notes changes to study design and contact/location information.
    Difference
    1%
    Check dated 2026-10-18T22:34:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T22:24:16.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The history page shows the contact link label updated from 'Find Contact Information' to 'Find contact information' and adds the revision tag 'Revision: v3.7.0', replacing the previous 'Revision: v3.6.6', reflecting a small UI text normalization and version update in the study record history.
    Difference
    0.2%
    Check dated 2026-09-20T20:41:08.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 is added to the record history and the previous v3.6.5 entry is removed, updating the list of revisions on the page.
    Difference
    0.1%
    Check dated 2026-08-30T15:43:58.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.